With the growth of genetic engineering, mice have become common as models of human diseases, which in turn has stimulated the development of techniques to monitor and image the murine cardiovascular system. Invasive methods are often more quantitative, but noninvasive methods are preferred when measurements must be repeated serially on living animals during development or in response to pharmacological or surgical interventions. Because of the small size and high heart rates in mice, high spatial and temporal resolutions are required to preserve signal fidelity. Monitoring of body temperature and the electrocardiogram is essential when animals must be anesthetized for a measurement or other procedure. Several other groups have developed cardiovascular imaging modalities suitable for murine applications, and ultrasound is the most widely used. Our group has developed and applied high-resolution Doppler probes and signal processing for measuring blood velocity in the heart and peripheral vessels of anesthetized mice noninvasively. We can measure cardiac filling and ejection velocities as indices of systolic and diastolic ventricular function and for timing of cardiac events; velocity pulse arrival times for determining pulse-wave velocity and arterial stiffness; peripheral velocity waveforms as indices of arterial resistance, compliance, and wave reflections; stenotic velocities for estimation of pressure drop and detection of vorticity; and tail artery velocity for determining systolic and diastolic blood pressure using a pressure cuff. These noninvasive methods are convenient and easy to apply and have been used to detect and evaluate numerous cardiovascular phenotypes in mutant mice.
Introduction
he ability to alter the genotype of the mouse has crei ated a need to evaluate the phenotypic changes that . occur in the animal during development and maturation (Cowley 1997) . However, the estimation and validation of "normal" values for many parameters in mice has been recent. A literature review reveals few publications prior to 1990 reporting mouse cardiovascular physiology; however, beginning in the mid-1990s, the number of publications involving mice genetically engineered to model human physiology and pathophysiology has increased exponentially. The mutations, whether targeted or random, can alter the structure, anatomy, pathology, and physiology of cells, organs, or systems in ways that are often subtle and unpredictable and that may change with time (Chien 1996; James et al. 1998; Kass et al. 1998) . Available methods for evaluating the cardiovascular systems of mice include dissection and microscopy for evaluating pathology, imaging with various modalities for displaying anatomy (Hoit and Walsh 1998) , and invasive techniques for measuring physiological variables (Doevendans et al. 1998) . In response to the need for serial assessment of function, several groups have developed and applied implantable pressure and flow sensors that incorporate telemetry (Mitchell et al. 1998) . The major problems in adapting methods for use in mice relate to the small size and high heart rates, which place extreme demands on both spatial and temporal resolution (Dawson 1991) . We focus here on noninvasive methods that can be used both to evaluate cardiovascular physiology and function in anesthetized mice and serially to follow development, aging, or the effects of surgical or pharmacological interventions.
Anesthesia
The use of anesthesia, which is required for most studies in living mice, is problematic in physiological and pharmacological studies because all agents alter cardiovascular control in some way. Larger domesticated animals can often be studied in the conscious unanesthetized state using implantable sensors either with or without telemetry because the animals are accustomed to humans and can be trained either to lie quietly or to exercise (Hanley et al. 1975; Hartley et al. 1978) . Mice have also been studied in the awake state (Desai et al. 1997; Yang et al. 1999b ); however, they are usually under stress in the laboratory situation, and it is more difficult to perform controlled studies in awake mice unless telemetry is used to minimize handling and interaction with humans (Gehrmann et al. 2000; Johansson et al. 1999; Mitchell et al. 1998) . Therefore, anesthesia is usually used to provide a consistent and controlled setting in which to study mice, recognizing that the type of agent must be chosen carefully to minimize the effect on the system under study. We have used a variety of agents including inhaled isoflurane gas (Hartley et al. 2000) , intraperitoneal sodium pentobarbital , etomidate , and a rodent "cocktail" mixture consisting of ketamine, xylazine, and acepromazine . Induction and recovery are faster with gas anesthesia, and we use the mixture for studies of relatively short duration. Pentobarbital, etomidate, and isoflurane gas maintain heart rate at physiological levels, but the rodent cocktail slows heart rate significantly in mice while maintaining blood pressure. As with any form of anesthesia, it is important to monitor the electrocardiogram (ECG 1 ) and respiration and to maintain body temperature during experimental procedures in mice .
Interventions
Many phenotypes are subtle, and mice can often accommodate the mutations by using compensatory mechanisms to maintain blood pressure and cardiac output ). Thus, resting values for these and other parameters may be nearly normal, and interventions must be performed to reveal phenotypic differences in the response to stress. Interventions can include inotropic Hartley et al. 1995 Hartley et al. , 1999 , chronotropic, and vasoactive (Banda et al. 1997; Hartley et al. 1997 ) pharmaceuticals, exercise (Desai et al. 1997; Spencer et al. 2000) , and/or surgical manipulations such as coronary occlusion (Briaud et al. 2001; Jones et al. 1999; Kurrelmeyer et al. 2000; Michael et al. 1995 Michael et al. , 1999 Patten et al. 1998; Verdouw et al. 1998) or aortic constriction (Hongo et al. 1997; Rockman et al. 1993; Zhang et al. 2000) . The ability to perform serial noninvasive studies and to measure the responses to interventions is powerful because the animal can be used as its own control, and it is not necessary to assess or assume so-called normal values.
Imaging Methods
Many of the methods used to evaluate the murine cardiovascular system noninvasively currently use some form of imaging. These methods include magnetic resonance imaging (Chacko et al. 2000; James et al. 1998; Siri et al. 1997; Wiesmann et al. 2000 ), x-ray angiography (Rockman et al. 1994) , two-dimensional (2-D 1 ) (Gardin et al. 1996; Scherrer-Crosbie et al. 1998; Youn et al. 1999 ) and M-mode (Fentzke et al. 2001; Hoit et al. 1995; Milner et al. 1999) 'Abbreviations used in this article: ApoE, apolipoprotein-E; 2-D, twodimensional; ECG, electrocardiogram; KO, knockout; LV, left ventricle; PWV, pulse-wave velocity.
ultrasound, and nuclear angiography ). All of these techniques have been adapted from human systems or those designed for larger animals and have marginal spatial and temporal resolutions (frame rates) when used with mice. At a typical mouse heart rate of 600/min or 10/sec, the standard video frame rate of 30/sec would produce only three images/cardiac cycle. Magnetic resonance imaging requires ECG and respiratory gating (Siri et al. 1997 ) averaged over several minutes, and the best 2-D ultrasound systems generate at most 150 frames/sec or 15 images/cardiac cycle (Youn et al. 1999) .
M-mode echocardiography, which displays the position and motion of reflecting structures along one line of sight as echo-depth versus time, is the most common noninvasive method for evaluating cardiac function in mice (Hoit and Walsh 1998) . It has the highest temporal resolution at 1 msec, but the limited sweep speeds available with clinical instruments are not optimal for mice. Nevertheless, it is possible to generate quantitative signals revealing left ventricular (LV 1 ) diameter throughout the cardiac cycle (Hoit and Walsh 1998; Kurrelmeyer et al. 2000) . From these signals, one can obtain several useful indices of LV function, including LV diameter and diameter shortening fraction and wall thickness and thickening fraction if the heart is known to be homogeneous. However, none of the imaging methods can estimate loading conditions or pressures that necessitate the use of more invasive methods.
Invasive Physiological Measurements
In larger animals, cardiovascular physiology and mechanics are usually assessed using pressure, flow, and/or dimension sensors either attached or inserted into the vessels or organs of interest (Hartley et al. 1978) . Several manufacturers are producing miniaturized versions of pressure (Lorenz and Robbins 1996; Wang et al. 2000; Williams et al. 1998) (Millar, Houston, Texas) , flow (Feldman et al. 2000a; Yang et al. 1999a ) (Transonic, Ithaca, New York), dimension (Feldman et al. 2000a; Kubota et al. 1998) (Sonometric, Ontario, Canada) , volume (Feldman et al. 2000b; Georgakopoulos et al. 1998) (Millar) , and telemetry (Mitchell et al. 1998 ) sensors and instrumentation (Data Sciences, St. Paul, Minnesota) specifically designed for use in mice. These methods are quantitative and allow good control of loading conditions, although size, resolution, fidelity, accuracy, and calibration are major concerns ). These methods all require precise surgical manipulations, chronic implantation of the sensors is problematic, and most of the studies are terminal and cannot be repeated in the same mouse . Several excellent reviews on evaluating cardiovascular physiology in mice are available (Hoit and Walsh 1998; James et al. 1998; Kass et al. 1998 ).
Noninvasive Physiological Methods
Among the noninvasive methods available for physiological studies in mice are ECG (Berul et al. 1996; Mitchell et al. 1998; Richards et al. 1953; Wehrens et al. 2000) (adapted from large animal and human systems), tail-cuff blood pressure (Krege et al. 1995) (adapted from rat systems), and M-mode and Doppler echocardiography (Gui et al. 1996; Youn et al. 1999 ) (using unmodified clinical systems). Several years ago, we began a program to design and optimize these and other techniques further so that we could make rapid, noninvasive serial measurements of cardiovascular function in mice during growth and development (Hartley et al. , 1997 . The goal was to facilitate quantitative assessment of cardiac and vascular phenotypes in mice (Hartley et al. 2000) .
Murine ECG
The first recording of an ECG in a mouse was reported more than 70 yr ago (Agduhr and Stenstrom 1929) , and Richards and colleagues (1953) performed seminal studies on location of the T-wave in the mid 1950s. A recent review summarizes the progress over the last 30 yr (Wehrens et al. 2000) . Early studies attempted to elucidate the electrical markers of repolarization and the Q-T segment in mice (Goldbarg et al. 1968) . At the time of this writing, 6-and/or 12-lead ECG recordings have been analyzed in transgenic and wild type mice to determine a variety of time intervals and conduction velocities (Berul et al. 1996 (Berul et al. ,1997 Sah et al. 1999; Vaidya et al. 1999 ). An ECG measurement in a mouse requires consideration of animal positioning, lead attachment, number of leads, noise suppression, signal fidelity, amplifier bandwidth, and status of the animal, among other requirements. Importantly, amplifiers with filters optimized for human ECG recording seriously compromise signal fidelity and distort timing when used in mice. A conventional amplifier with active-lead noise suppression and a bandwidth of 0.1 to 2 kHz is suitable for use in mice (Hartley et al. 2000) .
A related concern with mice is maintenance of body temperature during surgical and monitoring procedures. Significant alterations occur in heart rate and cardiac function with changes in temperature Richards et al. 1953) . Heat lamps or heating pads are therefore used commonly, but they are inconvenient and are often a source of 60-Hz electrical noise. By incorporating a lowvoltage heater into an ECG/restraint board, automatic thermal control can be achieved with no electrical interference (Hartley et al. 2000) . The board is shown in Figure 1 The 23 x 30-cm printed circuit board contains four stainless steel ECG electrodes, an array of 50 surface-mount resistors, a temperature sensor, a large ground plane, and electrical connections to an ECG amplifier and a temperature controller. Labeled on the Doppler tracing are the opening (o) and closing (c) of the mitral (m) and aortic (a) valves, peak ejection velocity (P) and acceleration (accel), and peak early (E) and late (A) filling velocities. From these signals, it is possible to obtain accurate timing of cardiac events such as pre-ejection time, filling and ejection times, and isovolumic contraction and relaxation times as indices of systolic and diastolic ventricular function. The rodent "cocktail" (which slows heart rate) was used for anesthesia.
Volume 43, Number 3 2002 mount resistors, and a temperature sensor. The anesthetized mouse is positioned over the resistor array, and each limb is taped to an electrode to which a small drop of electrode cream has been applied. A controller applies current to the resistor array to maintain the board (or the mouse) at a selected temperature. This general approach for ECG monitoring and thermal support is used during surgical procedures, during myocardial ischemia and reperfusion, and for invasive and noninvasive physiological measurements and interventions.
Murine Doppler System
Doppler instruments measure blood velocity by detecting the difference in frequency between an emitted burst of ultrasound (10 or 20 MHz) and the returning echoes from moving blood. In a pulsed Doppler system, the sample volume can be adjusted in depth by varying the range-gate or delay between transmission of the ultrasonic burst and sampling of the returning echoes. . The murine pulsed Doppler system was adapted from a modular instrument originally designed for use with implantable probes to measure blood flow in small vessels of dogs and rats (Gardiner et al. 1990; Hartley and Cole 1974) . For noninvasive applications in mice, small hand-held 0.5 Seconds Figure 2 Lead 2 ECG signals from a mouse before, during, and after occlusion of the left anterior descending (LAD) coronary artery. Although T-waves are not often seen in mice, there is a marked S-T elevation often with arrhythmias (as shown at 15 min) after occlusion. Usually the arrhythmias resolve and the S-T elevation is reduced with time. After reperfusion, the shape of the ECG is often significantly altered from the control as shown in the bottom panel.
probes ) and a high-fidelity signal processor were designed (Hartley et al. 2000) . The probes consist of a 1-mm-diameter 10-or 20-MHz ultrasonic crystal mounted at the end of a 2-mm-diameter 10-cm-long stainless steel tube. An epoxy lens is molded to the front face of the crystal to focus the sound beam at a depth of 4 to 6 mm. The resulting sample volume is less than 0.02 yj ul (0.3 mm diameter x 0.3 mm long) at the focus. The Doppler signal processor is a computer-based system, which Indus Instruments (Houston, Texas) designed to our specifications. The computer digitizes the audio Doppler signals at 125 kHz, generates a fast Fourier transform display in real-time, and also captures and displays up to four other signals such as ECG and pressure. After the signals are acquired, the number of the points used to calculate the fast Fourier transform and the update rate can be adjusted to optimize either temporal or frequency (velocity) resolution, depending on the application. The best velocity resolution is 5 mm/sec at 20 MHz; the maximum measurable velocity is 9.3 m/sec at 10MHz; and the best temporal resolution is 0.1 msec.
Nuclear Angiography 178n
First-pass nuclear angiography using Ta (T, /2 = 9.3 min) is a minimally invasive method to assess right and left ventricular ejection fractions in mice ). The human-sized nuclear camera is fitted with a pin-hole lens to achieve a 2-mm resolution with a frame rate of 160/sec. The resolution is marginal, but the method generates quantitative estimates of cardiac volumes in mice and is adequate to calculate ejection fractions. A jugular venous catheter is required for injection of 10 fil (20 mCi) of radionuclide, and images can be repeated at 30-min intervals or after several days by subcutaneous placement of the heparinlocked catheter.
Examples and Applications
In our facility, ECG, M-mode echocardiography, Doppler ultrasound, and l78 Ta nuclear imaging are used to evaluate cardiovascular function noninvasively in genetically engineered anesthetized mice with and without additional interventions. All of these measurements can be repeated within minutes and over several days or weeks so that animals can be used as their own controls and so that changes in function and responses to interventions can be followed over time. An example of cardiac Doppler signals from a mouse using a 10-MHz transducer placed at the base of the sternum and pointed toward the heart is shown in Figure 1 be isolated. From this approach, cardiac timing and several indices of LV systolic function (peak velocity and acceleration) and diastolic function (peak early and late filling velocities and their ratio) can be measured (Taffet et al. 1996) . The rodent cocktail was used to produce the slower heart rate shown in Figure 1 because at physiological rates (>500 beats/min), the early and late fillings waves are usually merged.
One of the models we have evaluated is an ischemiareperfusion model created by occluding (and reperfusing) the left anterior descending coronary artery in a mouse and then following cardiac function for several weeks or months using Doppler and nuclear imaging methods Michael et al. 1995 Michael et al. ,1999 . The ECG is monitored for S-T changes before, during, and after occlusion of the left anterior descending coronary artery to verify creation of ischemia, as shown in Figure 2 . A summary of ECG, nuclear angiography, and Doppler ultrasound data from control, sham-operated (but not occluded), permanently occluded, and occlusion/reperfusion mice taken 2 to 35 wk after operation is shown in Figure 3 . Ejection fraction is markedly reduced in both the occluded and reperfused groups compared with controls, but peak aortic velocity is only slightly lower. Pre-ejection time (another index of contractility) is elevated in both ischemic groups. When followed over several months, Doppler indices of systolic (peak aortic velocity) and diastolic function (peak early filling velocity) are initially depressed in sham-operated, occluded, and reperfused groups; however, function returns to control values in the sham-operated group after 2 wk and in the reperfused group after 4 wk . Ejection fraction remains depressed. It appears that the mice compensate for the presence of a significant aneurysm such that stroke volume and cardiac output are preserved at nearly normal levels.
Using a 20-MHz probe and a knowledge of anatomy to locate vessels and to estimate their angles, velocity signals can be obtained from many peripheral arterial sites, as shown in Figure 4 . By measuring peak and mean velocity and evaluating the shapes of the waveforms from several arterial sites, subtle changes in peripheral vascular impedance have been detected in an apolipoprotein-E (ApoE 1 ) knockout (KO 1 ) mouse model of atherosclerosis (Hartley et al. 2000) . In Figure 5 , aortic arch velocity (V)and acceleration (dV/dt) waveforms from an ApoE-KO and an agematched wild-type mouse are shown. The waveform from the ApoE-KO mouse has a biphasic acceleration phase in which the second peak is higher than the first peak. This phenotypic waveform may be caused by increased amplitude of wave reflections from the stenosed carotid bifurcation in ApoE-KO mice. ApoE-KO mice also have elevated aortic and mitral velocities due either to decreased crosssectional areas or to increased cardiac output and decreased total peripheral resistance. One of the applications for peripheral Doppler measurements of blood velocity is in the determination of arterial pulse wave velocity (PWV 1 ) as an index of arterial stiffness (Hartley et al. 1997) . Stiffer vessels propagate pressure and velocity waves faster than more compliant vessels. By recording velocity signals from two sites separated by a known distance and measuring the difference in pulse arrival times, we can determine the pulse transit time and calculate PWV, as shown in Figure 6 . In the past, sequential recordings were made at the two sites with a single probe and the arrival times were measured with respect to the ECG (Hartley et al. 1997) . Currently, simultaneous measurements of velocity are made at two sites by displaying one signal up and the other down on the bidirectional display. ApoE-KO mice have elevated PWV compared with wild-type mice (Hartley et al. 2000) , but in other models, the changes are not always apparent during rest. For instance, in alpha smooth muscle actin KO (aSMA" 7 ") mice (Schildmeyer et al. 2000) , the resting PWV is only slightly lower than in control mice, as shown in Figure 7 . However, the response to a bolus intravenous injection of phenylephrine is markedly reduced in aSMA" 7 " mice versus controls. In contrast, matrix GLA protein KO mice (Luo et al. 1997) , which have calcified arteries, have elevated PWV even at rest.
Another common method for stressing the cardiovascular system in mutant mice is a pressure overload model produced by constricting the aortic arch between the origins of the carotid arteries (Rockman et al. 1993) . This model is known to produce cardiac hypertrophy in normal mice, but it is difficult to measure or predict the degree of stenosis, the pressure drop, or the resulting hypertrophy. It is possible at the time of sacrifice to cannulate (and occlude) both carotid arteries to measure the pressure difference, but 
Figure 6
Example of how aortic pulse wave velocity (PWV) can be measured in a mouse by timing the arrival of the velocity pulse from two sites a known distance apart. When two probes are used simultaneously, one is displayed up and the other down on the spectral display. Alternatively, pulses from two sites measured sequentially using a single probe can be timed with respect to the electrocardiogram (ECG).
A pressure wave from a catheter in the carotid artery used in a validation study is also shown. Note that the time and amplitude scales have been expanded to improve the detection and resolution of the start or foot of the velocity waveforms.
this act is expected to alter flow (and the pressure drop) significantly. Using noninvasive Doppler methods, we have found differences in carotid velocity waveforms such that the ratio of peak velocities in the right and left carotid arteries measured at surgery is highly correlated with the degree of cardiac hypertrophy after 2 wk. We would also expect to find a high-velocity jet at the stenosis, although the jet is very small and difficult to locate sternally. Normal, n=19 aSMA-'", n=10 Matrix GLA'", n=3
Figure 7 Pulse-wave velocity in 19 normal, 10 alpha smooth muscle actin knockout (aSMA ' ), and three matrix GLA ' protein knockout mice. The response to an intravenous injection of phenylephrine is shown for the normal and aSMA~/ -mice. Figure 8 . We find that the pulsations in flow are increased in the right carotid artery proximal to the stenosis and decreased in the left carotid artery distal to the stenosis. In this mouse, the peak velocity at the stenotic jet is 3.5 m/sec, which corresponds to a pressure drop of 49 mmHg using the simplified Bernoulli equation (AP = 4V 2 ). Distal to the stenosis, we often detect disturbed flow characterized by rapid fluctuations in velocity (250 Hz in this example), consistent with vorticity. Thus, the hemodynamic perturbations produced by this common model are significant and largely unstudied.
One of the common criticisms of noninvasive Doppler measurements of velocity and ultrasonic measurements of LV dimensions is that the effect of loading conditions (blood pressure) cannot be determined (Hoit et al. 1997) . In response, we are developing an improved tail-cuff system to measure both systolic and diastolic arterial pressures noninvasively in anesthetized mice. Standard tail-cuff systems can determine only systolic pressure (Krege et al. 1995) ; however, by incorporating a Doppler probe to sense tail artery flow distal to the pressure cuff, diastolic pressure can also be determined, as shown in Figure 9 . To obtain a pressure reading, the pressure cuff is placed (deflated) on the proximal tail, and a 3.5-mm 20-MHz Doppler flow cuff (Hartley and Cole 1974) is positioned distal to the pressure cuff and oriented to detect flow in the tail artery. If no flow signal can be found, the board temperature is increased until flow is detected. As soon as flow becomes continuous, the pressure cuff is inflated until flow ceases and is then slowly deflated, as shown in Figure 9 . Flow reappears when the cuff pressure reaches systolic pressure and becomes continuous throughout the cardiac cycle when the cuff pressure reaches diastolic pressure. Thus it is also possible to assess afterload in mice noninvasively.
A Typical Noninvasive Study
In a typical study, the mouse is anesthetized and placed on the ECG/heater board (5-7 min). The board temperature is adjusted to 37°C, the quality of the ECG is assessed, and the electrode contact is optimized if needed. Next, cardiac Doppler signals are obtained from the mitral inflow track and from the aortic root using a 10-MHz probe placed as shown in Figure 1 Illustration of how systolic and diastolic blood pressure can be measured using a pressure cuff and a Doppler cuff placed on the tail of a mouse. The arterial pressure signal is shown for illustration purposes only and is not required. Flow in the tail artery occurs when arterial pressure exceeds cuff pressure, and the velocity waveform can be used to determine both systolic and diastolic blood pressures.
bers of mice using these relatively sophisticated but simpleto-apply noninvasive techniques.
Summary
A significant advantage of the measurement of velocity rather than volume flow is that it is not necessary to normalize the values (like blood pressure and ejection fraction) to body size if the cross-sectional area is considered normal (Dawson 1991; Hartley et al. 2000) . In fact, cardiac index (which is cardiac output normalized to body surface area) has units of velocity. Thus, so-called normal values for pressure, velocity, and ejection fraction are similar in all mammals. The magnitudes and waveforms of pressure and velocity in mice are almost indistinguishable from signals recorded from similar sites in humans and other species with the exception of the time scale (Nichols and O'Rourke 1998) . Indeed, many of the indices (Taffet et al. 1996) used to evaluate systolic (peak aortic velocity and acceleration) and diastolic function (peak E and A filling velocities and E:A ratio) in mice are derived from human indices. Arterial pulse wave velocity in mice is also similar to values reported for humans and other species (Nichols and O'Rourke 1998) . Thus, the similarity to humans and the ability to make noninvasive, accurate, high-fidelity measurements of pressure and velocity in mice makes the genetically engineered mouse a viable and useful model for evaluating the cardiovascular consequences of human diseases and for developing new methods for diagnosis and treatment.
